BioSpace News Archive

Zimmer Biomet Holdings, Inc., a global medical technology leader, announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the first quarter of 2022.

MicroVention, Inc., a subsidiary of Terumo and a global neurovascular company, announced the first U.S. clinical case of its next generation Flow Diverter, the FRED X device, at Thomas Jefferson University Hospital located in Philadelphia.

Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced that it will host a conference call and webcast on Thursday, March 3, 2022, at 5:00 p.m. ET to discuss a corporate update and financial results for the fourth quarter and full year 2021.

4D pharma plc today announces that the U.S. Food and Drug Administration (FDA) has cleared investigational new drug (IND) applications for two Live Biotherapeutics (LBPs), MRx0005 and MRx0029, for the treatment of Parkinson’s disease.

Harrow Health, Inc. (Nasdaq: HROW), an ophthalmic‑focused healthcare company, today announced that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) filing for AMP-100, the Company’s drug candidate for ocular surface anesthesia and intraoperative pain management during ocular surgery.

Palantir’s software will continue to power the digital operating system for the U.S. public health response to the pandemic.

Signifier Medical Technologies is Granted HCPCS Codes for eXcite OSA to Help Patients Access Innovative Technology.

Narcolepsy is a rare condition, which is often under diagnosed. The condition is characterized by excessive sleepiness, hallucination, sleep paralysis, excessive day time sleepiness, cataplexy, and automatic behaviors.

Medical mobility aid, also known as repositioning aid or device, is primarily used in healthcare facilities for mobility of patients.

Fact.MR – A Market research and competitive intelligence provider: The stroke post-processing software market concludes that the industry is expected to flourish the market size at a CAGR of 8.9% from 2022 to 2032, and the industry is likely to experience a Y-o-Y expansion rate of 26% of the market share in 2022, reaching market valuation US$ 178 Mn.